Ausgabe 9/2021
Inhalt (18 Artikel)
Phase II study of neoadjuvant chemotherapy with S-1 plus oxaliplatin for gastric cancer clinical T4 or N2-3
Akiko Serizawa, Hidekazu Kuramochi, Kiyoaki Taniguchi, Masaho Ota, Satoshi Katagiri, Takuji Yamada, Sho Kotake, Shunichi Ito, Kazuomi Suzuki, Masakazu Yamamoto
Metabolic shift of chronic myeloid leukemia patients under imatinib–pioglitazone regimen and discontinuation
Valquíria Mariane Oliveira Póvoa, Jeany Delafiori, Flávia Luísa Dias-Audibert, Arthur Noin de Oliveira, Ana Beatriz Pascoal Lopes, Erich Vinícius de Paula, Katia Borgia Barbosa Pagnano, Rodrigo Ramos Catharino
MPI-based bioinformatic analysis and co-inhibitory therapy with mannose for oral squamous cell carcinoma
Yufei Yao, Wei Liu, Jia Li, Maolin Zhou, Changxing Qu, Kun Wang
Investigation of the Osteopontin isoforms expression in patients with acute myeloid leukemia
Shirin Ferdowsi, Seyed H. Ghaffari, Sahar Tavakkoli Shiraji, Seyed Asadollah Mousavi, Saeed Mohammadi
Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro
Richard C. Zieren, Liang Dong, David J. Clark, Morgan D. Kuczler, Kengo Horie, Leandro Ferreira Moreno, Tung-Shing M. Lih, Michael Schnaubelt, Louis Vermeulen, Hui Zhang, Theo M. de Reijke, Kenneth J. Pienta, Sarah R. Amend
Submicron particle docetaxel intratumoral injection in combination with anti-mCTLA-4 into 4T1-Luc orthotopic implants reduces primary tumor and metastatic pulmonary lesions
Holly Maulhardt, Alyson Marin, Holly Hesseltine, Gere diZerega
Hypofractionated whole-breast radiotherapy in large breast size patients: is it really a resolved issue?
Riccardo Ray Colciago, Anna Cavallo, Maria Chiara Magri, Angelo Vitullo, Eliana La Rocca, Carlotta Giandini, Francesca Bonfantini, Serena Di Cosimo, Paolo Baili, Milena Sant, Emanuele Pignoli, Riccardo Valdagni, Laura Lozza, Maria Carmen De Santis
Combined evaluation of proliferation and apoptosis to calculate IC50 of VPA-induced PANC-1 cells and assessing its effect on the Wnt signaling pathway
Yeliz Ekici, Abdullah Yilmaz, Umut Can Kucuksezer, Sema Bilgic Gazioglu, Zeynep Dogusan Yamalioglu, Ali Osman Gurol, Thomas Linn, Feyza Nur Tuncer
Identification of the role of mono-ADP-ribosylation in colorectal cancer by integrated transcriptome analysis
Shuxian Zhang, Jiale Duan, Yanping Yang, Hanjuan Gong, Yi Tang, Ming Xiao, Ming Li, Qingshu Li, Yalan Wang
Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial
Eman Ghonaim, Sahar El-Haggar, Suzy Gohar
Combinatorial treatment with Gefitinib and Bay11-7085 sensitizes primary Gefitinib-resistant OSCC cells by influencing the EGFR- NFκB signaling axis
M. S. Sinto, Shaji Thomas, S. Kannan
Molecular analysis of cell survival and death pathways in the proteasome inhibitor bortezomib-resistant PC3 prostate cancer cell line
Ertan Kanbur, Ahmet Tarık Baykal, Azmi Yerlikaya
Knockdown of lncRNA HIF1A-AS2 increases drug sensitivity of SCLC cells in association with autophagy
Ebru Güçlü, Canan Eroğlu Güneş, Ercan Kurar, Hasibe Vural
Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer
Johann Ebadfardzadeh, Mandana Kazemi, Ali Aghazadeh, Monireh Rezaei, Milad Shirvaliloo, Roghayeh Sheervalilou
Isolation and characterization of a novel GRP78-specific single-chain variable fragment (scFv) using ribosome display method
Shima Shabani, Mehdi Forouzandeh Moghadam, Seyed Latif Mousavi Gargari
Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?
Saptarshi Sinha, Chanakya Nath Kundu
Correction to: Lentivirus-mediated RNAi knockdown of prostate-specific membrane antigen suppresses growth, reduces migration ability and the invasiveness of prostate cancer cells
Zhenghui Guo, Hai Huang, Lexiang Zeng, Tao Du, Kewei Xu, Tianxin Lin, Chun Jiang, Wen Dong, Yi Cao, Jieqing Chen, WeiDe Zhong, Jian Huang
Correction to: SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathway
Jin Li, Yiming Lai, Yi Cao, Tao Du, Lexiang Zeng, Ganping Wang, Xianju Chen, Jieqing Chen, Yongsheng Yu, Simin Zhang, Yiming Zhang, Hai Huang, Zhenghui Guo